{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:53:24Z","timestamp":1783630404106,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Science (CAMS) Initiative for Innovative Medicine","award":["2017-I2M-2-001"],"award-info":[{"award-number":["2017-I2M-2-001"]}]},{"name":"Chinese Academy of Medical Science (CAMS) Initiative for Innovative Medicine","award":["2016-I2M-1-008"],"award-info":[{"award-number":["2016-I2M-1-008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0913-6","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T13:20:06Z","timestamp":1525958406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature"],"prefix":"10.1186","volume":"19","author":[{"given":"Ru-Xuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"issue":"4","key":"913_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","volume":"45","author":"I Hussain","year":"2016","unstructured":"Hussain I, Garg A. Lipodystrophy syndromes. Endocrinol Metab Clin N Am. 2016;45(4):783\u201397.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"12","key":"913_CR2","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, et al. The diagnosis and Management of Lipodystrophy Syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101(12):4500\u201311.","journal-title":"J Clin Endocrinol Metab"},{"key":"913_CR3","doi-asserted-by":"publisher","unstructured":"Jeru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O. Clinical utility gene card for: familial partial lipodystrophy. Eur J Hum Genet. 2017;25(2). https:\/\/www.nature.com\/articles\/ejhg2016102\/ . https:\/\/doi.org\/10.1038\/ejhg.2016.102 .","DOI":"10.1038\/ejhg.2016.102"},{"issue":"1","key":"913_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/db14-0104","volume":"64","author":"K Kozusko","year":"2015","unstructured":"Kozusko K, Tsang VH, Bottomley W, Cho YH, Gandotra S, Mimmack M, Lim K, Isaac I, Patel S, Saudek V, et al. Clinical and molecular characterization of a novel PLIN1 frameshift mutation identified in patients with familial partial lipodystrophy. Diabetes. 2015;64(1):299\u2013310.","journal-title":"Diabetes"},{"issue":"8","key":"913_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMoa1007487","volume":"364","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y, Charpentier G, Auclair M, Delepine M, Barroso I, et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med. 2011;364(8):740\u20138.","journal-title":"N Engl J Med"},{"key":"913_CR6","doi-asserted-by":"crossref","unstructured":"Gupta N, Asi N, Farah W, Almasri J, Moreno Barrionuevo P, Alsawas M, Wang Z, Haymond MW, Brown RJ, Murad MH. Clinical features and management of non-HIV related lipodystrophy in children: a systematic review. J Clin Endocrinol Metab. 2017;102(2):363-74.","DOI":"10.1210\/jc.2016-2271"},{"issue":"1\u20132","key":"913_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11010-008-9998-8","volume":"326","author":"DL Brasaemle","year":"2009","unstructured":"Brasaemle DL, Subramanian V, Garcia A, Marcinkiewicz A, Rothenberg A. Perilipin a and the control of triacylglycerol metabolism. Mol Cell Biochem. 2009;326(1\u20132):15\u201321.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"913_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2001-12925","volume":"21","author":"EM Brunt","year":"2001","unstructured":"Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis. 2001;21(1):3\u201316.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"913_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","volume":"15","author":"R Zechner","year":"2012","unstructured":"Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, Madeo F. FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012;15(3):279\u201391.","journal-title":"Cell Metab"},{"issue":"11","key":"913_CR10","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1073\/pnas.101042998","volume":"98","author":"JT Tansey","year":"2001","unstructured":"Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 2001;98(11):6494\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"913_CR11","doi-asserted-by":"publisher","first-page":"34998","DOI":"10.1074\/jbc.M111.278853","volume":"286","author":"S Gandotra","year":"2011","unstructured":"Gandotra S, Lim K, Girousse A, Saudek V, O'Rahilly S, Savage DB. Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5). J Biol Chem. 2011;286(40):34998\u20135006.","journal-title":"J Biol Chem"},{"issue":"2","key":"913_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1152\/physrev.00024.2006","volume":"87","author":"DB Savage","year":"2007","unstructured":"Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87(2):507\u201320.","journal-title":"Physiol Rev"},{"issue":"40","key":"913_CR13","doi-asserted-by":"publisher","first-page":"42062","DOI":"10.1074\/jbc.M407462200","volume":"279","author":"V Subramanian","year":"2004","unstructured":"Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S, Shapiro L, Dolios G, Wang R, Lisanti MP, et al. Perilipin a mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem. 2004;279(40):42062\u201371.","journal-title":"J Biol Chem"},{"issue":"7","key":"913_CR14","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jc.2003-032140","volume":"89","author":"ED Javor","year":"2004","unstructured":"Javor ED, Moran SA, Young JR, Cochran EK, DePaoli AM, Oral EA, Turman MA, Blackett PR, Savage DB, O'Rahilly S, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab. 2004;89(7):3199\u2013207.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"913_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","volume":"83","author":"A Misra","year":"2004","unstructured":"Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore). 2004;83(1):18\u201334.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"913_CR16","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","volume":"177","author":"PW Mathieson","year":"1993","unstructured":"Mathieson PW, Wurzner R, Oliveria DB, Lachmann PJ, Peters DK. Complement-mediated adipocyte lysis by nephritic factor sera. J Exp Med. 1993;177(6):1827\u201331.","journal-title":"J Exp Med"},{"issue":"2","key":"913_CR17","doi-asserted-by":"publisher","first-page":"c35","DOI":"10.1159\/000076396","volume":"96","author":"KR Owen","year":"2004","unstructured":"Owen KR, Donohoe M, Ellard S, Clarke TJ, Nicholls AJ, Hattersley AT, Bingham C. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome). Nephron Clin Pract. 2004;96(2):c35\u20138.","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"913_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jmg.23.2.120","volume":"23","author":"J Kobberling","year":"1986","unstructured":"Kobberling J, Dunnigan MG. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet. 1986;23(2):120\u20137.","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"913_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000354716","volume":"124","author":"KM Thong","year":"2013","unstructured":"Thong KM, Xu Y, Cook J, Takou A, Wagner B, Kawar B, Ong AC. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA. Nephron Clin Pract. 2013;124(1\u20132):31\u20137.","journal-title":"Nephron Clin Pract"},{"issue":"22","key":"913_CR20","doi-asserted-by":"crossref","first-page":"16321","DOI":"10.1016\/S0021-9258(19)85424-8","volume":"268","author":"F Lin","year":"1993","unstructured":"Lin F, Worman HJ. Structural organization of the human gene encoding nuclear Lamin a and nuclear Lamin C. J Biol Chem. 1993;268(22):16321\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"913_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1469-7580.2007.00715.x","volume":"210","author":"T Samuel","year":"2007","unstructured":"Samuel T, Hoy WE, Douglas-Denton R, Hughson MD, Bertram JF. Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: the Weibel and Gomez method revisited. J Anat. 2007;210(5):578\u201382.","journal-title":"J Anat"},{"issue":"5","key":"913_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8(5):293\u2013300.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"913_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1681\/ASN.2014030278","volume":"26","author":"W Kriz","year":"2015","unstructured":"Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol. 2015;26(2):258\u201369.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"913_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502\u201317.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"913_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/01913123.2011.584657","volume":"35","author":"S Darouich","year":"2011","unstructured":"Darouich S, Goucha R, Jaafoura MH, Zekri S, Ben Maiz H, Kheder A. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct Pathol. 2011;35(4):176\u201382.","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"913_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0913-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T04:34:20Z","timestamp":1661229260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0913-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["913"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0913-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"3 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We obtained ethics approval from the Peking Union Medical College Hospital review boards. The patient and her parents were informed about the case report. After the discussion, the patient and her parents signed consent forms if they wanted to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and her parents for publication of this case report and the images in it. A copy of the written consent is available. The manuscript is also approved by all authors for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"111"}}